Literature DB >> 15047532

Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States.

Minggui Wang1, Daniel F Sahm, George A Jacoby, David C Hooper.   

Abstract

Although quinolone resistance commonly results from chromosomal mutation, recent studies indicate that such resistance can also be transferred on plasmids carrying the gene responsible, qnr. One hundred ten ciprofloxacin-resistant clinical isolates of Klebsiella pneumoniae and Escherichia coli from the United States were screened for the qnr gene by PCR and Southern hybridization of plasmid DNA. Conjugation experiments were done with azide-resistant E. coli J53 as the recipient and selection with azide and sulfonamide, a resistance frequently linked to qnr. EcoRI and BamHI digests of qnr-hybridizing plasmids were subjected to electrophoresis on agarose gels and probed with qnr by Southern hybridization. qnr was detected in 8 (11.1%) of 72 K. pneumoniae strains. These eight positive strains were from six states in the United States. qnr was not found in any of the 38 E. coli strains tested. Quinolone resistance was transferred from seven of the eight probe-positive strains. Transconjugants with qnr-hybridizing plasmids had 32-fold increases in ciprofloxacin MICs relative to E. coli J53. For all eight strains, the sequence of qnr was identical to that originally reported. By size and restriction digests, four plasmids were related to the first-reported plasmid, pMG252, and three were different. Five new qnr plasmids encoded FOX-5 beta-lactamase, as did pMG252, but two others produced SHV-7 extended-spectrum beta-lactamase. Transferable plasmid-mediated quinolone resistance associated with qnr is now widely distributed in quinolone-resistant clinical strains of K. pneumoniae in the United States. Plasmid-determined quinolone resistance contributes to the increasing quinolone resistance of K. pneumoniae isolates and to the linkage previously observed between resistance to quinolones and the latest beta-lactam antibiotics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047532      PMCID: PMC375335          DOI: 10.1128/AAC.48.4.1295-1299.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Microcin B17 blocks DNA replication and induces the SOS system in Escherichia coli.

Authors:  M Herrero; F Moreno
Journal:  J Gen Microbiol       Date:  1986-02

2.  Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program.

Authors:  G S Itokazu; J P Quinn; C Bell-Dixon; F M Kahan; R A Weinstein
Journal:  Clin Infect Dis       Date:  1996-10       Impact factor: 9.079

3.  Rapid isoelectric focusing of plasmid-mediated beta-lactamases with Pharmacia PhastSystem.

Authors:  S Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

4.  A multiple plasmid-containing Escherichia coli strain: convenient source of size reference plasmid molecules.

Authors:  F L Macrina; D J Kopecko; K R Jones; D J Ayers; S M McCowen
Journal:  Plasmid       Date:  1978-06       Impact factor: 3.466

5.  Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

Authors:  E Lautenbach; B L Strom; W B Bilker; J B Patel; P H Edelstein; N O Fishman
Journal:  Clin Infect Dis       Date:  2001-09-14       Impact factor: 9.079

6.  Quinolone resistance from a transferable plasmid.

Authors:  L Martínez-Martínez; A Pascual; G A Jacoby
Journal:  Lancet       Date:  1998-03-14       Impact factor: 79.321

7.  Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.

Authors:  D L Paterson; L Mulazimoglu; J M Casellas; W C Ko; H Goossens; A Von Gottberg; S Mohapatra; G M Trenholme; K P Klugman; J G McCormack; V L Yu
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

8.  Intrinsic resistance of Mycobacterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpA.

Authors:  C Montero; G Mateu; R Rodriguez; H Takiff
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

9.  Evaluation of five different methods to prepare bacterial extracts for the identification of beta-lactamases by isoelectric focusing.

Authors:  T Arstila; G A Jacoby; P Huovinen
Journal:  J Antimicrob Chemother       Date:  1993-12       Impact factor: 5.790

10.  Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type beta-lactamase.

Authors:  J M Rodríguez-Martínez; A Pascual; I García; L Martínez-Martínez
Journal:  J Antimicrob Chemother       Date:  2003-09-01       Impact factor: 5.790

View more
  68 in total

1.  Evolution of an incompatibility group IncA/C plasmid harboring blaCMY-16 and qnrA6 genes and its transfer through three clones of Providencia stuartii during a two-year outbreak in a Tunisian burn unit.

Authors:  C Arpin; L Thabet; H Yassine; A A Messadi; J Boukadida; V Dubois; L Coulange-Mayonnove; C Andre; C Quentin
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

2.  Mobilizable IncQ-related plasmid carrying a new quinolone resistance gene, qnrS2, isolated from the bacterial community of a wastewater treatment plant.

Authors:  Gabriele Bönemann; Michael Stiens; Alfred Pühler; Andreas Schlüter
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

3.  Molecular analysis of the simultaneous production of two SHV-type extended-spectrum beta-lactamases in a clinical isolate of Enterobacter cloacae by using single-nucleotide polymorphism genotyping.

Authors:  Dóra Szabó; Melissa A Melan; Andrea M Hujer; Robert A Bonomo; Kristine M Hujer; Christopher R Bethel; Katalin Kristóf; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

4.  Plasmid-mediated quinolone resistance in isolates obtained in german intensive care units.

Authors:  Daniel Jonas; Klaus Biehler; Doris Hartung; Bettina Spitzmüller; Franz D Daschner
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

5.  Vibrio parahaemolyticus chromosomal qnr homologue VPA0095: demonstration by transformation with a mutated gene of its potential to reduce quinolone susceptibility in Escherichia coli.

Authors:  Tomoo Saga; Mitsuo Kaku; Yoshikuni Onodera; Shinichiro Yamachika; Kenichi Sato; Hiroyuki Takase
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

6.  Further identification of plasmid-mediated quinolone resistance determinant in Enterobacteriaceae in Turkey.

Authors:  Hasan Nazic; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

7.  High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae.

Authors:  Mitchell J Schwaber; Shiri Navon-Venezia; David Schwartz; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

8.  Detection of qnr in clinical isolates of Escherichia coli from Korea.

Authors:  Jin-Yong Jeong; Hyun Jung Yoon; Eun Sil Kim; Yoola Lee; Sang-Ho Choi; Nam Joong Kim; Jun Hee Woo; Yang Soo Kim
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

9.  Pentapeptide repeat proteins.

Authors:  Matthew W Vetting; Subray S Hegde; J Eduardo Fajardo; Andras Fiser; Steven L Roderick; Howard E Takiff; John S Blanchard
Journal:  Biochemistry       Date:  2006-01-10       Impact factor: 3.162

10.  Association of plasmid-mediated quinolone resistance with extended-spectrum beta-lactamase VEB-1.

Authors:  Laurent Poirel; Marc Van De Loo; Hedi Mammeri; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.